Hemo Organic Limited

Hemo Organic Ltd has submitted its Annual Report for the Financial Year 2025-26, in compliance with SEBI Listing Regulations. The report includes the Notice convening the 34th Annual General Meeting (AGM), scheduled for Tuesday, September 8, 2026, at 3:00 PM IST via Video Conferencing. The AGM will cover standard business, including the presentation of financial statements and reports. Key dates for shareholders include the record date on September 1, 2026, and the period for remote e-voting from September 5 to September 7, 2026. The Annual Report is accessible on the company's website.

Hemo Organic Ltd has submitted its Annual Report for the Financial Year 2025-26, in compliance with SEBI Listing Regulations. The report includes the Notice convening the 34th Annual General Meeting (AGM), scheduled for Tuesday, September 8, 2026, at 3:00 PM IST via Video Conferencing. The AGM will cover standard business, including the presentation of financial statements and reports. Key dates include a record date of September 1, 2026, and the book closure period from September 1 to September 8, 2026. The Annual Report is accessible on the company's website.

Hemo Organic Ltd announced the outcome of its Board Meeting held on August 13, 2026. The board approved the appointment of M/s. V S S B & Associates as the new Statutory Auditor for a term of five years, replacing M/s. M A A K & Associates. Additionally, the company approved the notice for its 34th Annual General Meeting (AGM), the Director's Report, and related documents. The AGM is scheduled to be held on September 8, 2026, via Video Conference/Other Audio-Visual Means. Jitendra Parmar & Associates has been appointed as the scrutinizer for the e-voting process.

Hemo Organic Ltd announced the appointment of M/s. V S S B & Associates, Chartered Accountants, as its new Statutory Auditor. This appointment, recommended by the Audit Committee, is for a term of five consecutive years, commencing from the conclusion of the 34th Annual General Meeting until the conclusion of the 39th AGM. The previous auditor, M/s. M A A K & Associates, will complete their tenure at the 34th AGM. The company also approved the convening of the 34th AGM on September 8, 2026, via Video Conference and appointed a scrutinizer for the e-voting process.

Hemo Organic Ltd announced that its statutory auditor, M/s. M A A K & Associates, Chartered Accountants, has completed its maximum permissible tenure as per the Companies Act, 2013. The auditor was initially appointed in 2017 and re-appointed for a second term in 2022. Their tenure concludes at the 34th Annual General Meeting, scheduled for September 8, 2026. The company has provided the necessary disclosures regarding this change as per SEBI regulations.

Hemo Organic Ltd announced board meeting outcomes on August 4, 2026. The board approved the appointment of M/s. Jitendra Parmer & Associates as the Secretarial Auditor for FY 2025-26 and M/s. Umesh Khese & Co. as the Internal Auditor for FY 2026-27. These appointments are to ensure compliance with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Detailed profiles and reasons for appointment were provided as per SEBI circulars.

Hemo Organic Ltd announced the appointment of M/s. Jitendra Parmer & Associates as Secretarial Auditor for FY 2025-26 and M/s. Umesh Khese & Co. as Internal Auditor for FY 2026-27. The appointments were approved during a Board of Directors meeting held on August 4th, 2026. The company provided detailed disclosures as required by SEBI regulations regarding these appointments. The Secretarial Auditor is a peer-reviewed firm with extensive experience in corporate laws, while the Internal Auditor brings over three decades of professional practice in taxation and corporate governance.

Hemo Organic Ltd announced the outcome of its Board Meeting held on July 15, 2026. The Board approved and took on record the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report. The meeting also transacted other businesses as per the circulated agenda. The financial results were prepared in accordance with SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015.

Hemo Organic Limited has submitted its un-audited financial results for the quarter ended June 30, 2026, along with a limited review report from statutory auditors M/s. MAAK & Associates. The report indicates a qualified opinion due to the inability to confirm trade receivables and payables balances. The company has prepared these results in accordance with Indian Accounting Standards (Ind AS) 34.

Hemo Organic Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors approved and took on record the results along with the Limited Review Report. The company's board meeting was held on July 15, 2026, to discuss and approve these financial statements prepared in accordance with Ind AS 34. The auditor's report included a qualified opinion due to unconfirmed trade receivables and payables.